Cystadane

This page contains recent news articles, when available, and an overview of Cystadane but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Orphan Europe SARL acquires Jazz Pharm-Cystadane Rights from Jazz …  -  Mar 7, 2007
US - Orphan Europe SARL acquired the world wide rights of Cystadane from Jazz Pharmaceuticals Inc, a manufacturer of prescription pharmaceuticals. Pay-Per-View - deals - Alacra Store

Q4 2004 Orphan Medical Earnings Conference Call - Final.  -  Feb 16, 2005
Cystadane and Antizol generated 10.7 million on a combined basis. In addition to building Xyrem sales, our specialty sales force and marketing team ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

Orphan Medical Reports 2005 First-Quarter Results; Product Revenues …  -  Apr 26, 2005
Quarterly Antizol and Cystadane revenue was $2.8 million, a slight increase from $2.7 million for the same period in the prior year. ... $4.95 - Business Wire - ECNext

Stocks on the Rise.  -  May 13, 2005
Quarterly Antizol and Cystadane revenue was $2.8 million, a slight increase from $2.7 million for the same period in the prior year. ... $4.95 - M2 Presswire - ECNext

JAZZ Has Also Been Added To Naked Short List Today.  -  Jun 19, 2007
Its products include Xyrem for the treatment of cataplexy and excessive daytime sleepiness in patients with narcolepsy; Cystadane for the treatment of ... $4.95 - M2 Presswire - ECNext

DELTAGEN REPORTS 2006 2ND QTR NET INCOME OF $1.483 MIL. | …  -  Nov 1, 2006
Antizol and Cystadane ... was $2.8 million for the quarter ended June 30, 2004 an increase of approximately ... Biotech Financial Reports ... Pay-Per-View - Biotech Financial Reports - HighBeam Research

Press Release: JAZZ Has Also Been Added To Naked Short List Today. - ...  -  Jun 19, 2007
Its products include Xyrem for the treatment of cataplexy and excessive daytime sleepiness in patients with narcolepsy; Cystadane for the treatment of ... Pay-Per-View - M2 Presswire - HighBeam Research

Cancer, maladies rares, DMLA, diabète : 51 nouveaux médicaments …  -  Feb 6, 2008
CYSTADANE : seul médicament indiqué spécifiquement dans le traitement de l'homocystinurie, dans ses trois formes enzymatiques. ... Guide des démarches

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.